Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-25-040448
Filing Date
2025-04-29
Accepted
2025-04-29 06:00:49
Documents
25
Period of Report
2025-06-12

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm252376-3_def14a.htm   iXBRL DEF 14A 1588876
6 GRAPHIC bc_directors-4c.jpg GRAPHIC 92201
7 GRAPHIC bc_netloss-4c.jpg GRAPHIC 65578
8 GRAPHIC bc_tsr-4c.jpg GRAPHIC 82069
9 GRAPHIC eq_annual-bw.jpg GRAPHIC 15751
10 GRAPHIC lg_mersanatherapeu-4c.jpg GRAPHIC 27276
11 GRAPHIC px_25mersanaproxy1pg01-4c.jpg GRAPHIC 272355
12 GRAPHIC px_25mersanaproxy1pg02-4c.jpg GRAPHIC 216320
13 GRAPHIC sg_alejandracarvajal-bw.jpg GRAPHIC 11350
14 GRAPHIC sg_martinhuber-bw.jpg GRAPHIC 12635
  Complete submission text file 0001104659-25-040448.txt   5043959

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mrsn-20241231.xsd EX-101.SCH 10136
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mrsn-20241231_def.xml EX-101.DEF 3980
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mrsn-20241231_lab.xml EX-101.LAB 36951
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mrsn-20241231_pre.xml EX-101.PRE 6573
27 EXTRACTED XBRL INSTANCE DOCUMENT tm252376-3_def14a_htm.xml XML 534551
Mailing Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139 617-498-0020
Mersana Therapeutics, Inc. (Filer) CIK: 0001442836 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38129 | Film No.: 25882451
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)